Ha Tay Pharmaceutical JSC (HNX:DHT)
Vietnam · Delayed Price · Currency is VND 55,800
-500 (-0.89%)
At close: Aug 13, 2026
Ha Tay Pharmaceutical JSC Revenue
Ha Tay Pharmaceutical JSC had revenue of 575.92B VND in the quarter ending June 30, 2026, with 0.27% growth. This brings the company's revenue in the last twelve months to 2.48T, up 14.79% year-over-year. In the year 2025, Ha Tay Pharmaceutical JSC had annual revenue of 2.40T with 15.13% growth.
Revenue (ttm)
2.48T
Revenue Growth
+14.79%
P/S Ratio
2.04
Revenue / Employee
4.23B
Employees
586
Market Cap
5.05T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.40T | 315.69B | 15.13% |
| Jan 1, 2025 | 2.09T | 87.05B | 4.35% |
| Jan 1, 2024 | 2.00T | 161.91B | 8.81% |
| Jan 1, 2023 | 1.84T | 228.03B | 14.17% |
| Jan 1, 2022 | 1.61T | -397.11B | -19.79% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DHG Pharmaceutical JSC | 5.45T |
| Traphaco JSC | 2.77T |
| Imexpharm | 2.32T |
| Domesco Medical Import - Export Joint-Stock | 2.13T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.87T |
| Cuu Long Pharmaceutical JSC | 1.27T |
| OPC Pharmaceutical JSC | 1.15T |
| Vidipha Central Pharmaceutical JSC | 979.05B |